Navigation Links
Defense Department to Support Fragile X Research
Date:12/29/2009

WASHINGTON, Dec. 29 /PRNewswire-USNewswire/ -- The National Fragile X Foundation applauds the United States Congress and President Barack Obama for including Fragile X Syndrome for the first time ever within a select group of conditions eligible for research funding from the U.S. Department of Defense.

The new law, signed by President Obama on Dec. 19, designates $50 million through the FY 2010 Department of Defense Appropriations Act for the Peer Reviewed Medical Research Program (PRMRP). Fragile X is one of a select group of priority conditions that are eligible for funding under the PRMRP.

"We are thrilled that Congress and the President have recognized this need in our communities," said Robert Miller, Executive Director of The National Fragile X Foundation (NFXF). "Fragile X poses a serious challenge to families and communities everywhere, challenges that are much more acutely felt by our military families. This funding is a promise of support and a means to a better outcome for those affected by Fragile X."

Fragile X syndrome and its associated disorders are caused by a genetic mutation on the X chromosome and impact over one million Americans. Symptoms of Fragile X Syndrome include intellectual, physical and occupational disabilities. Behavioral problems, including autism, are also common among those with Fragile X.

"As the only Member of Congress who has a child with Fragile X, I understand the true value of priority designation for this genetic disorder," said Congressman Gregg Harper (R-Miss.). "Thousands of families across America are battling this disease and this research funding opens a new chapter of hope as we continue to learn how Fragile X impacts individuals. I'm thankful for the leadership of Senator Thad Cochran of Mississippi, the Ranking Republican on the Senate Appropriations Committee, who helped secure these federal dollars."

The National Fragile X Foundation funds and advocates for expanded Fragile X research, supports efforts to bring best medical practices to all impacted patients and their families, and promotes public awareness and education of Fragile X. The NFXF will work closely with the DoD to leverage this new investment in research to accelerate the march toward more effective targeted treatments and eventually a cure for Fragile X.

Through a NFXF sponsored program, since 2004 nearly 1000 grass roots advocates have visited their Members of Congress, advocating for innovative research funding and awareness initiatives.

SOURCE The National Fragile X Foundation


'/>"/>
SOURCE The National Fragile X Foundation
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Peregrine Pharmaceuticals Presents Promising Antiviral Data at 2009 Chemical and Biological Defense Science & Technology Conference
2. FY 2010 Federal Biodefense Spending
3. Powerful Image Registration and Recognition Software Unveiled for Medical, Satellite, and Defense Imaging Industries
4. NC Biomanufacturers Supply Defense for World vs. Flu
5. Inimex Pharmaceuticals begins First Clinical Study of an Innate Defense Regulator
6. New Weapon in BioDefense Research: NanoLogix Kit Speeds Rapid Diagnostics of Anthrax and Bubonic Plague
7. ArunA Biomedical Awarded Department of Defense Contract to Further Develop Environmental Biosensor for National Security
8. PharmAthene Presents Data for SparVax(TM) and Valortim(R), a Novel Vaccine and Anti-Toxin for the Prevention and Treatment of Anthrax Infection at the 7th Annual ASM Biodefense Meeting
9. Innovative Beverage Products Launches New Product Designed to Enhance the Bodys Immune Defense
10. Parion Sciences Receives NIH Biodefense Grant to Study Novel Methods for Mitigating Radiation-Induced Lung Injury
11. Bell Ventures Launches Breakthrough Radical Defense Skin Care Ingredient
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)...  Sequenom, Inc. (NASDAQ: SQNM ), a ... the development of innovative products and services, announced today ... States denied its petition to review decisions ... U.S. Patent No. 6,258,540 (",540 Patent") are not patent ... Supreme Court,s Mayo Collaborative Services v. Prometheus Laboratories decision.  ...
(Date:6/27/2016)... PHILADELPHIA , June 27, 2016  Liquid ... today announced the funding of a Sponsored Research ... study circulating tumor cells (CTCs) from cancer patients.  ... changes in CTC levels correlate with clinical outcomes ... therapies. These data will then be employed to ...
(Date:6/24/2016)... ... ... Researchers at the Universita Politecnica delle Marche in Ancona combed medical journal articles ... findings are the subject of a new article on the Surviving Mesothelioma website. ... blood, lung fluid or tissue of mesothelioma patients that can help point doctors to ...
(Date:6/23/2016)... 2016 A person commits a crime, and the ... track the criminal down. An outbreak of foodborne ... Administration (FDA) uses DNA evidence to track down the bacteria ... far-fetched? It,s not. The FDA has increasingly used a complex, ... foodborne illnesses. Put as simply as possible, whole genome sequencing ...
Breaking Biology Technology:
(Date:6/3/2016)... June 3, 2016 ... Nepal hat ein ... hochsicherer geprägter Kennzeichen, einschließlich Personalisierung, Registrierung und ... der Produktion und Implementierung von Identitätsmanagementlösungen. Zahlreiche ... im Januar teilgenommen, aber Decatur wurde als ...
(Date:6/2/2016)... NEW YORK , June 2, 2016   The ... (Weather), is announcing Watson Ads, an industry-first capability in which ... advertising, by being able to ask questions via voice or ... Marketers have long ... with the consumer, that can be personal, relevant and valuable; ...
(Date:6/1/2016)... YORK , June 1, 2016 ... Technology in Election Administration and Criminal Identification to Boost ... to a recently released TechSci Research report, " Global ... By Region, Competition Forecast and Opportunities, 2011 - 2021", ... 24.8 billion by 2021, on account of growing security ...
Breaking Biology News(10 mins):